Comparison of two Mycoplasma genitalium real-time PCR detection methodologies.
ABSTRACT Established in-house quantitative PCR (qPCR) assays to detect the Mycoplasma genitalium adhesion protein (MgPa) and the 16S rRNA gene were found to be comparable for screening purposes, with a kappa value of 0.97 (95% confidence interval [CI], 0.94 to 1.01) and no difference in bacterial load quantified (P = 0.4399).
- [Show abstract] [Hide abstract]
ABSTRACT: In recent years, quantitative real-time PCR tests have been extensively developed in clinical microbiology laboratories for routine diagnosis of infectious diseases, particularly bacterial diseases. This molecular tool is well-suited for the rapid detection of bacteria directly in clinical specimens, allowing early, sensitive and specific laboratory confirmation of related diseases. It is particularly suitable for the diagnosis of infections caused by fastidious growth species, and the number of these pathogens has increased recently. This method also allows a rapid assessment of the presence of antibiotic resistance genes or gene mutations. Although this genetic approach is not always predictive of phenotypic resistances, in specific situations it may help to optimize the therapeutic management of patients. Finally, an approach combining the detection of pathogens, their mechanisms of antibiotic resistance, their virulence factors and bacterial load in clinical samples could lead to profound changes in the care of these infected patients.Expert Review of Molecular Diagnostics 09/2012; 12(7):731-54. · 4.09 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Background. Mycoplasma genitalium (MG) is an emerging sexually transmitted infection (STI) that is potentially associated with serious reproductive tract sequelae in women. This study aimed to estimate rates of MG incidence and treatment failure and provide estimates of organism load for MG infections.Methods. 1110 women aged 16 to 25 years were recruited from primary care clinics in Australia. Women were tested for MG at baseline, 6 months and 12 months and MG organism load was measured by quantitative PCR. All MG positive cases were also screened for MG 23S rRNA gene point mutations shown to confer azithromycin resistance using high resolution melt following PCR.Results. MG incidence rate was 1.3 per 100 person years (95% CI: 0.8, 2.3) (n=14) and women reporting three or more sex partners in the last 12 months had an increased rate of incident infection [RR=5.1 (95%CI: 1.3, 19.6)]. There were 3 cases of MG re-infection with a re-infection rate of 0.8 per 100 person years (95% CI: 0.1, 0.9). Organism load was higher for prevalent than incident infection (p=0.04). There were 3 cases of treatment failure cases [9.4% (95%CI: 2.0, 25.0)] and organism load was higher in the cases with treatment failure than the successfully treated cases (p<0.01). An MG 23S rRNA mutation was detected in 5 cases; 3 cases of treatment failure and 2 successfully treated cases.Conclusions. While MG incidence was relatively low, testing should be recommended for women considered to be at increased risk of infection based on sexual history. Our results also suggest that organism load might be important in influencing azithromycin treatment failure.Clinical Infectious Diseases 01/2013; · 9.37 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Approximately, 15-20% of all cancers worldwide are caused by infectious agents. Understanding the role of infectious agents on cancer development might be useful for developing new approaches to its prevention. Mycoplasma genitalium is a clinically important sexually transmitted pathogen that has been associated with several human diseases. There have been a few studies suggestive of probable roles of Mycoplasma genitalium in cancer development, including prostate and ovarian cancers and lymphomas, but the role of this microorganism like other Mycoplasma species in neoplasia is still conjectural. Considering the prevalence of Mycoplasma genitalium infections and also the emergence of resistant strains, Mycoplasma genitalium needs more attention in the infectious agent cancer-causing research area.Asian Pacific journal of cancer prevention: APJCP 01/2013; 14(6):3425-8. · 1.50 Impact Factor
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2011, p. 1140–1142
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
Vol. 49, No. 3
Comparison of Two Mycoplasma genitalium Real-Time
PCR Detection Methodologies?
Jimmy Twin,1,2* Nicole Taylor,1,2Suzanne M. Garland,1,2,3,4Jane S. Hocking,5Jennifer Walker,5
Catriona S. Bradshaw,6,7Christopher K. Fairley,5,6and Sepehr N. Tabrizi1,2,3
Department of Microbiology and Infectious Diseases, The Royal Women’s Hospital, Melbourne, Australia1;
Murdoch Childrens Research Institute, Melbourne, Australia2; Department of Obstetrics and Gynaecology,
University of Melbourne, Australia3; Department of Microbiology, The Royal Children’s Hospital,
Melbourne, Australia4; Melbourne School of Population Health, University of Melbourne,
Australia5; Melbourne Sexual Health Centre, Melbourne, Australia6; and Department of
Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia7
Received 18 November 2010/Returned for modification 20 December 2010/Accepted 24 December 2010
Established in-house quantitative PCR (qPCR) assays to detect the Mycoplasma genitalium adhesion
protein (MgPa) and the 16S rRNA gene were found to be comparable for screening purposes, with a kappa
value of 0.97 (95% confidence interval [CI], 0.94 to 1.01) and no difference in bacterial load quantified
(P ? 0.4399).
Limited knowledge exists regarding the epidemiology of My-
coplasma genitalium in the general population (3, 9, 12). In the
absence of adequate and reliable culture and approved com-
mercial assay techniques, most laboratories use in-house nu-
cleic acid amplification tests (NAATs) for detection of this
bacterium. Quantitative PCR (qPCR) assays have been de-
signed for a variety of M. genitalium targets (2, 5, 7, 8, 14, 15,
17, 18, 20, 22), though the most cited qPCR assays are the one
described by Jensen et al., which targets a 78-bp region of the
M. genitalium adhesion protein (MgPa) and has a reported
sensitivity of ?5 copies per reaction (14), and an assay by
Yoshida et al. (22), which targets a 517-bp region of the 16S
rRNA gene with a sensitivity of ?10 copies per reaction. Both
of these targets are present as a single copy in the M. genitalium
genome (10). Hardick et al. described a multiplex assay that
incorporated both the MgPa and 16S rRNA gene qPCR assays
(11) and found that the 16S rRNA target did not detect 59 of
607 samples (9.7%) in which MgPa was detected. Lack of
detection by the 16S rRNA gene component could possibly be
attributed to competition when the two targets were multi-
plexed, and the authors recommended further testing in single-
To investigate the issue of varying sensitivities between the
MgPa and 16S rRNA gene assays, an initial experiment was
carried out to determine the detection limit of each assay. A
clinical sample equivalent to 1,200 copies/?l of M. genitalium
was diluted 1:4 to extinction and run in triplicate. Each assay
consisted of 5 ?l template in a 20-?l reaction on the LightCy-
cler 480 real-time PCR system (Roche Diagnostics), using
PCR conditions as described previously (8, 22). The MgPa
assay was able to detect ?6 copies/reaction of M. genitalium in
three replicate reactions, and the 16S rRNA gene assay de-
tected ?23 copies per reaction. Both assays were able to detect
M. genitalium down to a single copy although in only one of
three replicate reactions each. Further analysis on a separate
clinical sample diluted to approximately six copies per reaction
was carried out with 12 replicates. The MgPa assay detected M.
genitalium in eight of these reactions (mean quantification cy-
cle [Cq] ? 39.50; standard deviation [SD] ? 0.94), and the 16S
rRNA gene assay detected M. genitalium in seven (mean Cq ?
39.37; SD ? 0.80).
Testing was then carried out on 845 self-collected vaginal
swab samples (from 761 individuals) obtained as part of the
Chlamydia Incidence and Re-Infection Rates Study (CIRIS)
(21), which consisted of specimens collected at the recruitment
and at a 12-month follow-up. Sample processing and DNA
extraction were as described previously (19). Each sample was
initially screened for the 16S rRNA gene target; then samples
were stored at ?30°C for a median of 25 months (average ?
22.2; range ? 1 to 29) before subsequent testing for the MgPa
gene and retesting with the 16S RNA gene assay in cases where
the assays gave discordant results. Nine DNA samples tested
negative or yielded a low human ?-globin gene signal, indicat-
ing inadequate sampling, and were removed from subsequent
Also removed from the study were three DNA samples from
different patients in which M. genitalium was detected by the
16S rRNA assay (with 15, 68, and 129 copies per reaction;
* Corresponding author. Mailing address: Department of Microbi-
ology & Infectious Diseases, The Royal Women’s Hospital, Locked
Bag 300, Parkville, Vic. 3052, Australia. Phone: (61-3) 8345 3679. Fax:
(61-3) 9344 2713. E-mail: email@example.com.
?Published ahead of print on 5 January 2011.
TABLE 1. Clinical cohort screening sample results
No. of samples with MgPa result
Cq ? 40.48, 38.06, and 35.22, respectively) but which tested
negative with both the MgPa gene and 16S rRNA gene assay
after being kept in storage at ?30°C for 16 to 26 months.
Further repeated testing failed to generate PCR amplicons,
indicating that either multiple freeze-thaw cycles or extended
storage at ?30°C was likely to have resulted in degradation of
DNA samples. The potentially detrimental effect of freezing
on M. genitalium samples and DNA has been reported in other
studies (4, 13), and work in our own laboratory has shown
levels of M. genitalium DNA to significantly reduce after three
freeze-thaw cycles (data not shown). In future studies, freezing
of samples destined for M. genitalium testing is not recom-
mended, to avoid potential degradation.
Of the 40 samples found to be positive by one or both
methods (Table 1), 38 (88.4%) were positive by both assays
and 2 (4.7%) were positive by the MgPa assay only. Based on
these results, the sensitivity and specificity of the 16S rRNA
gene assay compared to those of the MgPa were 95.0% (95%
confidence interval [CI], 0.831 to 0.994) and 100%, respectively
(1). Kappa analysis of these two methods gave a score of 0.973
(95% CI, 0.936 to 1.010), indicating an “almost perfect” agree-
ment between these two assays (16). The two discordant sam-
ples in this study with M. genitalium detected only by the MgPa
assay were from the same patient but at different time periods
(recruitment and at a 12-month follow up), with concentrations
of 81 and 86 copies per reaction (Cq values ? 37.06 and 36.98,
Of the 38 samples that were positive for M. genitalium by
both assays, only one sample showed evidence of slight degra-
dation between retesting, showing a reduction from 411 copies
per reaction initially with the 16S rRNA gene assay (Cq ?
33.16) to fewer than 10 copies per reaction when retested with
both assays 26 months later (Cq ? 40.0 to 40.3). With the
remaining 37 samples, the calculated concentrations for the
MgPa assay ranged from 9 copies to 2.6 ? 105copies per
reaction (mean ? 3.0 ? 103; SD ? 5.5 ? 103), while results for
the 16S rRNA assay ranged from 34 copies to 1.7 ? 105copies
per reaction (mean ? 2.5 ? 103; SD ? 4.1 ? 103). Using a
paired t test, the concentrations given for each sample were not
statistically different overall (P ? 0.44). This was confirmed by
Deming regression analysis (6) giving a near-perfect line of
best fit (Fig. 1).
In summary, the MgPa and 16S rRNA gene assays appear
equally suitable for the detection of M. genitalium in vaginal
swabs. Further work is warranted to determine how effective
these methods are for other clinical specimen types and to
identify the reason(s) why two samples, from the same pa-
tient, gave rise to amplicons in the MgPa assay and not the
16S rRNA gene assay. These data will inform clinicians and
researchers regarding the comparative performances of the
two commonly used in-house assays for the detection of M.
genitalium and are of particular relevance as routine testing
and screening for the bacterium become increasingly com-
We thank the staff and students at the Women’s Centre for Infec-
tious Diseases (Royal Women’s Hospital, Victoria, Australia) for their
assistance in this study.
1. Altman, D. G., and J. M. Bland. 1994. Diagnostic tests. 1: Sensitivity and
specificity. BMJ 308:1552.
2. Blaylock, M. W., O. Musatovova, J. G. Baseman, and J. B. Baseman. 2004.
Determination of infectious load of Mycoplasma genitalium in clinical sam-
ples of human vaginal cells. J. Clin. Microbiol. 42:746–752.
3. Bradshaw, C. S., et al. 2009. Mycoplasma genitalium in men who have sex
with men at male-only saunas. Sex. Transm. Infect. 85:432–435.
4. Carlsen, K. H., and J. S. Jensen. 2010. Mycoplasma genitalium PCR: does
freezing of specimens affect sensitivity? J. Clin. Microbiol. 48:3624–3627.
5. Chalker, V. J., K. Jordan, T. Ali, and C. Ison. 2009. Real-time PCR detection
of the mg219 gene of unknown function of Mycoplasma genitalium in men
with and without non-gonococcal urethritis and their female partners in
England. J. Med. Microbiol. 58:895–899.
6. Deming, W. E. 1943. Statistical adjustment of data. John Wiley & Sons, New
7. Dupin, N., et al. 2003. Detection and quantification of Mycoplasma geni-
talium in male patients with urethritis. Clin. Infect. Dis. 37:602–605.
8. Edberg, A., et al. 2008. A comparative study of three different PCR assays for
detection of Mycoplasma genitalium in urogenital specimens from men and
women. J. Med. Microbiol. 57:304–309.
9. Ekiel, A., J. Jozwiak, and G. Martirosian. 2009. Mycoplasma genitalium: a
significant urogenital pathogen? Med. Sci. Monit. 15:RA102–RA106.
10. Fraser, C. M., et al. 1995. The minimal gene complement of Mycoplasma
genitalium. Science 270:397–403.
11. Hardick, J., et al. 2006. Performance of the Gen-Probe transcription-medi-
ated amplification research assay compared to that of a multitarget real-time
PCR for Mycoplasma genitalium detection. J. Clin. Microbiol. 44:1236–1240.
12. Jensen, J. S. 2004. Mycoplasma genitalium: the aetiological agent of urethritis
and other sexually transmitted diseases. J. Eur. Acad. Dermatol. Venereol.
13. Jensen, J. S., E. Bjornelius, B. Dohn, and P. Lidbrink. 2004. Comparison of
first void urine and urogenital swab specimens for detection of Mycoplasma
genitalium and Chlamydia trachomatis by polymerase chain reaction in pa-
tients attending a sexually transmitted disease clinic. Sex. Transm. Dis. 31:
14. Jensen, J. S., E. Bjornelius, B. Dohn, and P. Lidbrink. 2004. Use of TaqMan
5? nuclease real-time PCR for quantitative detection of Mycoplasma geni-
FIG. 1. Scatter plot with Deming line of best fit. The log10trans-
formed M. genitalium concentrations derived from the MgPa gene
assay were plotted against those of the 16S rRNA gene assay (n ? 37;
range, 0.94 to 4.42), with a Deming list of best fit (0.09 ? 0.98x). H0:
Constant bias ? 0. H1: Constant bias ? 0. Constant bias ? 0.09. 95%
CI, ?0.69 to 0.87. Standard error (SE) ? 0.383. P ? 0.8168. H0:
Proportional bias ? 0. H1: Proportional bias ? 0. Constant bias ? 0.98.
95% CI, 0.73 to 1.22. SE ? 0.121. P ? 0.8397.
VOL. 49, 2011NOTES1141
talium DNA in males with and without urethritis who were attendees at a
sexually transmitted disease clinic. J. Clin. Microbiol. 42:683–692.
15. Jensen, J. S., M. B. Borre, and B. Dohn. 2003. Detection of Mycoplasma
genitalium by PCR amplification of the 16S rRNA gene. J. Clin. Microbiol.
16. Landis, J. R., and G. G. Koch. 1977. The measurement of observer agree-
ment for categorical data. Biometrics 33:159–174.
17. Masue, N., et al. 2007. System for simultaneous detection of 16 pathogens
related to urethritis to diagnose mixed infection. Int. J. Urol. 14:39–42.
18. McKechnie, M. L., et al. 2009. Simultaneous identification of 14 genital
microorganisms in urine by use of a multiplex PCR-based reverse line blot
assay. J. Clin. Microbiol. 47:1871–1877.
19. Stevens, M. P., et al. 2010. Development and evaluation of an ompA quan-
titative real-time PCR assay for Chlamydia trachomatis serovar determina-
tion. J. Clin. Microbiol. 48:2060–2065.
20. Svenstrup, H. F., et al. 2005. Development of a quantitative real-time PCR
assay for detection of Mycoplasma genitalium. J. Clin. Microbiol. 43:3121–
21. Walker, J., et al. 2009. The prevalence of Chlamydia and Mycoplasma
genitalium in a cohort of Australian young women, abstr. P2.78, p. 221.
Abstr. 18th ISSTDR Conference. London, United Kingdom.
22. Yoshida, T., et al. 2002. Quantitative detection of Mycoplasma genitalium
from first-pass urine of men with urethritis and asymptomatic men by real-
time PCR. J. Clin. Microbiol. 40:1451–1455.
1142NOTES J. CLIN. MICROBIOL.